The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC related information was provided by the message!
  • No CSPEC computed assertion could be determined for this classification!

  • See Evidence submitted by expert panel for details.

Variant: NM_000527.5(LDLR):c.1444G>C (p.Asp482His)

CA10585454

251844 (ClinVar)

Gene: LDLR
Condition: hypercholesterolemia, familial
Inheritance Mode: Semidominant inheritance
UUID: c4514ebd-5f3b-4eb3-b62b-68702b42de00
Approved on: 2023-06-23
Published on: 2024-09-25

HGVS expressions

NM_000527.5:c.1444G>C
NM_000527.5(LDLR):c.1444G>C (p.Asp482His)
NC_000019.10:g.11113620G>C
CM000681.2:g.11113620G>C
NC_000019.9:g.11224296G>C
CM000681.1:g.11224296G>C
NC_000019.8:g.11085296G>C
NG_009060.1:g.29240G>C
ENST00000252444.10:c.1702G>C
ENST00000559340.2:c.1444G>C
ENST00000560467.2:c.1324G>C
ENST00000558518.6:c.1444G>C
ENST00000252444.9:c.1698G>C
ENST00000455727.6:c.940G>C
ENST00000535915.5:c.1321G>C
ENST00000545707.5:c.1063G>C
ENST00000557933.5:c.1444G>C
ENST00000558013.5:c.1444G>C
ENST00000558518.5:c.1444G>C
ENST00000559340.1:c.165G>C
ENST00000560467.1:c.924G>C
NM_000527.4:c.1444G>C
NM_001195798.1:c.1444G>C
NM_001195799.1:c.1321G>C
NM_001195800.1:c.940G>C
NM_001195803.1:c.1063G>C
NM_001195798.2:c.1444G>C
NM_001195799.2:c.1321G>C
NM_001195800.2:c.940G>C
NM_001195803.2:c.1063G>C

Likely Pathogenic

Met criteria codes 6
PP4 PP3 PM5 PM2 PS3_Moderate PS4_Supporting
Not Met criteria codes 16
PS2 PS1 PP1 PM3 PM1 PM4 PM6 BA1 BS2 BS4 BS3 BS1 BP2 BP3 BP4 PVS1

Evidence Links 1

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Familial Hypercholesterolemia VCEP
The NM_000527.5(LDLR):c.1444G>C (p.Asp482His) variant is classified as Likely Pathogenic for Familial Hypercholesterolemia by applying ACMG/AMP evidence codes PS3_Moderate, PM2, PM5, PP3, PP4 and PS4_Supporting as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (specification version 1.2) on 23 June 2023. PM2: This variant is absent from gnomAD (gnomAD v2.1.1). PP3: REVEL=0.993. PM5: 3 other missense variants in the same codon: - NM_000527.5(LDLR):c.1444G>A (p.Asp482Asn) (ClinVar ID 161284) - Pathogenic by these guidelines; - NM_000527.5(LDLR):c.1444G>T (p.Asp482Tyr) (ClinVar ID 251845) - Uncertain significance by these guidelines; - NM_000527.5(LDLR):c.1445A>G (p.Asp482Gly) (ClinVar ID 251846) - Likely Pathogenic by these guidelines; There is 1 variant in the same codon classified as Pathogenic by these guidelines. PS3_Moderate: Level 2 assay: PMID 31587492 (Kizhakkedath P et al., 2019) - HEK-293T cells. In immunoblots of the mutants, only the precursor form was observed (~120 kDa) and the mature receptor form was absent. PS4_Supporting, PP4: Variant meets PM2 and is identified in at least 2 index cases who fulfill Simon Broome criteria for FH (1 case in PMID 11313767 (Heath KE et al., 2001), 1 case in PMID 10559517 (Graham CA et al., 1999)).
Met criteria codes
PP4
Variant meets PM2 and is identified in 2 unrelated index cases who fulfill clinical criteria for FH (see PS4 for details), after alternative causes of high cholesterol were excluded.
PP3
REVEL=0.993. It is above 0.75, so PP3 is met.
PM5
3 other missense variants in the same codon: - NM_000527.5(LDLR):c.1444G>A (p.Asp482Asn) (ClinVar ID 161284) - Pathogenic by these guidelines - NM_000527.5(LDLR):c.1444G>T (p.Asp482Tyr) (ClinVar ID 251845) - Uncertain significance by these guidelines - NM_000527.5(LDLR):c.1445A>G (p.Asp482Gly) (ClinVar ID 251846) - Likely Pathogenic by these guidelines There is 1 variant in the same codon classified as Pathogenic by these guidelines.
PM2
This variant is absent from gnomAD (gnomAD v2.1.1). So, PM2 is met.
PS3_Moderate
Level 2 assays PMID 31587492- HEK-293T cells. In immunoblots of the mutants, only the precursor form was observed (~120 kDa) and the mature receptor form was absent. So, PS3_Moderate was met.

PS4_Supporting
Variant meets PM2 and is identified in 2 index cases (1 case with Simon-Broome criteria of FH in PMID: 11313767 (Heath KE et al., 2001), 1 case with Simon-Broome criteria of FH in PMID: 10559517 (Graham CA et al., 1999)). So, PS4_Supporting is met.
Not Met criteria codes
PS2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PS1
No other missense variant in the same codon with the same amino acid change.
PP1
No evidence available
PM3
No evidence available
PM1
Not in exon 4. Not a cysteine residue.
PM4
No in-frame deletions/insertions
PM6
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BA1
This variant is absent from gnomAD (gnomAD v2.1.1).
BS2
No evidence available
BS4
No evidence available
BS3
No evidence available
BS1
This variant is absent from gnomAD (gnomAD v2.1.1).
BP2
No evidence available
BP3
No in-frame deletions/insertions
BP4
REVEL=0.993.
PVS1
Not a null variant
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.